CINECA IRIS Institutional Research Information System

PETRINI, IACOPO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.628
AS - Asia 5.025
EU - Europa 4.079
SA - Sud America 644
Continente sconosciuto - Info sul continente non disponibili 493
AF - Africa 297
OC - Oceania 23
Totale 21.189
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.316
IT - Italia 1.653
SG - Singapore 1.590
CN - Cina 1.513
SE - Svezia 607
HK - Hong Kong 599
BR - Brasile 539
VN - Vietnam 388
DE - Germania 382
GB - Regno Unito 336
BG - Bulgaria 283
CA - Canada 228
FR - Francia 190
JP - Giappone 175
CI - Costa d'Avorio 166
TR - Turchia 154
FI - Finlandia 145
IN - India 142
RU - Federazione Russa 136
KR - Corea 115
UA - Ucraina 77
BD - Bangladesh 64
NL - Olanda 45
AT - Austria 38
IQ - Iraq 38
PK - Pakistan 38
PL - Polonia 36
AR - Argentina 34
MX - Messico 33
BE - Belgio 32
SA - Arabia Saudita 29
ZA - Sudafrica 29
CH - Svizzera 27
ID - Indonesia 24
ES - Italia 22
PH - Filippine 22
SN - Senegal 21
AU - Australia 19
VE - Venezuela 19
CZ - Repubblica Ceca 18
KE - Kenya 18
UZ - Uzbekistan 18
EC - Ecuador 17
MY - Malesia 16
JM - Giamaica 15
IL - Israele 14
NG - Nigeria 14
MA - Marocco 13
CO - Colombia 10
EG - Egitto 10
TW - Taiwan 10
AZ - Azerbaigian 8
OM - Oman 8
TH - Thailandia 8
UY - Uruguay 8
GR - Grecia 7
IE - Irlanda 7
LT - Lituania 7
TT - Trinidad e Tobago 7
DZ - Algeria 6
JO - Giordania 6
HN - Honduras 5
IR - Iran 5
LB - Libano 5
NP - Nepal 5
PY - Paraguay 5
AE - Emirati Arabi Uniti 4
BO - Bolivia 4
CR - Costa Rica 4
ET - Etiopia 4
GT - Guatemala 4
HR - Croazia 4
HU - Ungheria 4
NZ - Nuova Zelanda 4
PA - Panama 4
PE - Perù 4
PS - Palestinian Territory 4
BH - Bahrain 3
BJ - Benin 3
BY - Bielorussia 3
CL - Cile 3
DO - Repubblica Dominicana 3
GA - Gabon 3
KG - Kirghizistan 3
SK - Slovacchia (Repubblica Slovacca) 3
SV - El Salvador 3
AM - Armenia 2
AO - Angola 2
BM - Bermuda 2
CY - Cipro 2
EE - Estonia 2
GE - Georgia 2
KW - Kuwait 2
KZ - Kazakistan 2
LK - Sri Lanka 2
LU - Lussemburgo 2
LY - Libia 2
MD - Moldavia 2
NI - Nicaragua 2
PT - Portogallo 2
Totale 20.673
Salva come PNG Salva come JPEG
Città #
Ashburn 1.113
Singapore 893
Woodbridge 893
Ann Arbor 786
Houston 722
San Jose 667
Fairfield 628
Santa Clara 612
Hong Kong 582
Dallas 473
Chandler 416
Serra 363
Beijing 341
Seattle 292
Sofia 282
Shanghai 277
Milan 240
Wilmington 217
Cambridge 213
New York 210
Los Angeles 196
Boardman 194
London 187
Hefei 174
Council Bluffs 172
Abidjan 166
Tokyo 162
Ottawa 157
Florence 150
Princeton 149
Pisa 128
Lauterbourg 114
Lawrence 111
Medford 111
Seoul 105
Turin 96
Munich 89
Ho Chi Minh City 88
Jacksonville 79
Izmir 77
Des Moines 73
Dearborn 68
Hanoi 67
São Paulo 64
Nanjing 59
Frankfurt am Main 58
Istanbul 57
Buffalo 56
Redondo Beach 50
Chicago 48
San Diego 46
Rome 45
Bremen 40
Helsinki 37
Düsseldorf 36
Nuremberg 36
Dong Ket 32
Orem 32
Lancaster 31
Vienna 29
Turku 28
Warsaw 28
Columbus 27
Brussels 26
Atlanta 25
Nanchang 25
Shenyang 25
Redwood City 24
Chennai 22
Toronto 22
Westminster 22
Dakar 21
Montreal 21
Phoenix 21
Rio de Janeiro 21
Hebei 20
Lucca 19
Multan 19
Washington 19
Changsha 18
Fuzhou 18
Mumbai 18
Bern 17
Tashkent 17
Brooklyn 16
Guangzhou 16
Manchester 16
Nairobi 16
Dhaka 15
Stockholm 15
Cascina 14
Johannesburg 14
Kunming 14
Pune 14
San Francisco 14
Brasília 13
Da Nang 13
Denver 13
Jiaxing 13
Jüchen 13
Totale 14.641
Salva come PNG Salva come JPEG
Nome #
Increased production of inflammatory cytokines by circulating monocytes in mesial temporal lobe epilepsy: A possible role in drug resistance 358
PD-L1 mRNA expression in plasma-derived exosomes is associated with response to anti-PD-1 antibodies in melanoma and NSCLC 329
The Droplet Digital PCR: A New Valid Molecular Approach for the Assessment of B-RAF V600E Mutation in Hairy Cell Leukemia 250
Mesenchymal cells inhibit expansion but not cytotoxicity exerted by gamma-delta T cells 236
Comparison of digital PCR systems for the analysis of liquid biopsy samples of patients affected by lung and colorectal cancer 221
Human adult mesangiogenic progenitor cells reveal an early angiogenic potential, which is lost after mesengenic differentiation 221
MESENCHYMAL CELLS INHIBIT IL2 AND ZOLENDRONATE-INDUCED ?/d T-LYMPHOCYTES 219
ED-B fibronectin expression is a marker of epithelial-mesenchymal transition in translational oncology 216
Association of KRAS mutations in cell-free circulating tumor DNA with occurrence of resistance to TKIs in NSCLC 210
EXTENSIVE ANALYSIS OF T CELL RECEPTOR GAMMA (TCRG) GENE REARRANGEMENTS REVEALS A SIMILAR REPERTOIRE IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA) AND IN HYPEREOSINOPHILIC SYNDROME (HES) 206
Growth Factor Content in Human Sera Affects the Isolation of Mesangiogenic Progenitor Cells (MPCs) from Human Bone Marrow 205
Contribution of KRAS mutations and c.2369C > T (p.T790M) EGFR to acquired resistance to EGFR-TKIs in EGFR mutant NSCLC: a study on circulating tumor DNA 204
The amount of activating EGFR mutations in circulating cell-free DNA is a marker to monitor osimertinib response 204
The Role of Microenvironment in Bispecific Antibodies Treatment in Multiple Myeloma 198
A multicenter phase II study of the combination of oxaliplatin, irinotecan and capecitabine in the first-line treatment of metastatic colorectal cancer 198
Arsenic trioxide and ascorbic acid interfere with the BCL2 family genes in patients with myelodysplastic syndromes: an ex-vivo study. 197
GTF2I mutations are common in thymic epithelial tumors but not in hematological malignancies 195
Oncologia 194
CD57 and γδ T‐cell receptor expression in nodal metastatic spread of melanoma 192
Pten expression and Kras mutations as predictors of benefit from cetuximab plus irinotecan (CETIRI) in metastatic colorectal cancer (MCRC) patients (PTS) 190
Capecitabine (C) in combination with Irinotecan (I) and Oxaliplatin (O) (XELOXIRI) in patients with metastatic colorectal cancer (MCRC): preliminary results of a pilot study by Gruppo Oncologico Nord Ovest (G.O.N.O.) 189
Is there a role for palliative gastrectomy in asymptomatic metastatic gastric cancer? 186
Gene-network analysis predicts clinical response to immunotherapy in patients affected by NSCLC 185
Clinical utility of Next Generation Sequencing of plasma cell-free DNA for the molecular profiling of patients with NSCLC at diagnosis and disease progression 185
MDS: An Integrated Workup for a Correct Diagnosis 185
TCR GAMMA CLONALITY ASSESSED BY NGS DOES NOT HELP TO DISTINGUISH EGPA FROM HES 185
Droplet digital PCR represents a new sensitive method for detecting B-RAFV600E mutation at diagnosis and during the follow-up of patients affected by hairy cell leukemia 182
EGFR and AKT1 overexpression are mutually exclusive and associated with a poor survival in resected gastric adenocarcinomas 182
Third-Line Chemotherapy with Irinotecan plus 5-Fluorouracil in Caucasian Metastatic Gastric Cancer Patients 181
Myelodysplastic syndromes: advantages of a combined cytogenetic and molecular diagnostic workup 181
Understanding the Mechanisms of Resistance in EGFR-Positive NSCLC: From Tissue to Liquid Biopsy to Guide Treatment Strategy 180
PET based target volume delineation in hypofractionated radiotherapy in locally advanced NSCLC: A single institution experience 179
Patients with NSCLC may display a low ratio of p.T790M vs. activating EGFR mutations in plasma at disease progression: implications for personalised treatment 179
Capecitabine ( C ), in combination with irinotecan ( I ) and oxaliplatin ( O ) (XELOXIRI) as first-line treatment of metastatic colorectal cancer (MCRC): results of a pilot study by the Gruppo Oncologico Nord-Ovest (G.O.N.O.) 176
The increase in activating EGFR mutation in plasma is an early biomarker to monitor response to osimertinib: a case report 176
Molecular analysis of cell-free circulating DNA for the diagnosis of somatic mutations associated with resistance to tyrosine kinase inhibitors in non-small-cell lung cancer. 175
Nanotopography Induced Human Bone Marrow Mesangiogenic Progenitor Cells (MPCs) to Mesenchymal Stromal Cells (MSCs) Transition 173
Detection of ALK and KRAS Mutations in Circulating Tumor DNA of Patients With Advanced ALK-Positive NSCLC With Disease Progression During Crizotinib Treatment 172
Loss of PTEN expression in colorectal cancer (CRC) metastases (METS) predicts lack of activity of cetuximab plus irinotecan treatment 171
The mitochondrial citrate carrier, SLC25A1, drives stemness and therapy resistance in non-small cell lung cancer 171
LOW RPS14 EXPRESSION IS FREQUENTLY FOUND IN NON-5Q-MYELODYSPLASTIC SYNDROMES 171
Array-based comparative genomic hybridization analysis to identify prognostic markers for resected pancreatic cancer. 169
First line treatment of metastatic colorectal cancer (MCRC) with the combination of capecitabine ( C ), irinotecan ( I ) and oxaliplatin ( O ) (XELOXIRI): a pilot study by the Gruppo Oncologico Nord Ovest (G.O.N.O.) 168
Implications of KRAS mutations in acquired resistance to treatment in NSCLC 168
Hypertermic Intrathoracic Chemotherapy (HITHOC) for thymoma: a narrative review on indications and results 168
Tolerability of FOLFOXIRI regimen after surgical resection for pancreatic cancer. 167
Comparison of Real-Time PCR and Droplet Digital PCR for the Determination of JAK2V617F Mutation in Ph'-Negative Myeloproliferative Neoplasms 167
Systemic therapy, clinical outcomes, and overall survival in locally advanced or metastatic pulmonary carcinoid: A brief report 166
EGFR and AKT1 overexpression are mutually exclusive and associated with a poor survival in resected adenocarcinomas of the stomach and gastro-esophageal junction 164
HUMAN MESENCHYMAL CELLS INHIBIT IL2 AND ZOLEDRONATE-INDUCED GAMMA/DELTA T-CELLS. 163
Sequential chemotherapy with capecitabine and irinotecan followed by capecitabine and oxaliplatin in elderly vulnerable patients (pts) with metastatic colorectal cancer (MCRC) 160
Copy number aberrations of BCL2 and CDKN2A/B identified by array-CGH in thymic epithelial tumors 159
Amivantamab in the Treatment of Metastatic NSCLC: Patient Selection and Special Considerations 158
The combination of capecitabine (C), irinotecan (I) and oxaliplatin (O) (XELOXIRI) as first line treatment of metastatic colorectal cancer (MCRC): Preliminary results of a pilot study by the Gruppo Oncologico Nord-Ovest (G.O.N.O.) 158
Loss of 18q22.3 involving the carboxypeptidase of glutamate-like gene is associated with poor prognosis in resected pancreatic cancer 158
CLONOTYPE AND MUTATIONAL PATTERN IN TCRGD LARGE GRANULAR LYMPHOCYTE LEUKEMIA 157
EGFR-TKIs in non-small-cell lung cancer: Focus on clinical pharmacology and mechanisms of resistance 157
A phase II (PhII) trial of sorafenib (S) in combination with 5-fluorouracil (5FU) continuous infusion (c.i.) in patients (pts) with advanced hepatocellular carcinoma (HCC): Preliminary data. 157
Triplet combination of fluoropyrimidines, oxaliplatin, and irinotecan in the first-line treatment of metastatic colorectal cancer 156
Medical treatment of malignant pleural mesothelioma relapses 156
From the beginning to resistance: study of plasma monitoring and resistance mechanisms in a cohort of patients treated with osimertinib for advanced T790M-positive NSCLC 155
PTEN expression and KRAS mutations on primary tumors and metastases in the prediction of benefit from cetuximab plus irinotecan for patients with metastatic colorectal cancer 153
Insulin-like growth factor-1 receptor and phosphorylated AKT-serine 473 expression in 132 resected thymomas and thymic carcinomas 153
Contribution of KRAS mutations and c.2369C > T (p.T790M) EGFR to acquired resistance to EGFR-TKIs in EGFR mutant NSCLC: a study on circulating tumor DNA 152
Stereotactic body radiation therapy for the treatment of pleural metastases in patients with thymoma: A retrospective review of 22 patients 150
A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors. 149
OCTREOTIDE LAR SUITABLE TREATMENT FOR G1-G2 THORACIC NEUROENDOCRINE TUMORS (T-NET): SINGLE CENTER EXPERIENCE 149
Defining TCRγδ lymphoproliferative disorders by combined immunophenotypic and molecular evaluation 149
Mesenchymal Stem Cell in Pancreatic Islet Transplantation 147
Gene network Analysis Defines a Subgroup of Small Cell Lung Cancer patients With Short Survival 147
Impaired function of gamma-delta lymphocytes in melanoma patients. 147
TCR GAMMA CLONALITY ASSESSED BY NGS DOES NOT HELP TO DISTINGUISH EOSINOPHILOIA IN EGPA FROM HES 147
Integrating Liquid Biopsy and Radiomics to Monitor Clonal Heterogeneity of EGFR-Positive Non-Small Cell Lung Cancer 147
A multiparametric approach to improve the prediction of response to immunotherapy in patients with metastatic NSCLC 146
GAMMA-DELTA T-LYMPHOCYTE SPECIFIC CLONES ARE INVOLVED IN THE GRAFT-VERSUS-MYELOMA AND IN THE GRAFT-VERSUS-HOST DISEASE IN MULTIPLE MYELOMA PATIENTS AFTER NON-MYELOABLATIVE TRANSPLANTATION. 144
Best practices for the management of thymic epithelial tumors: A position paper by the Italian collaborative group for ThYmic MalignanciEs (TYME) 144
Are MSCs angiogenic cells? New insights on human nestin-positive bone marrow-derived multipotent cells 143
Loss of PTEN expression in colorectal cancer (CRC) metastases (mets) but not in primary tumors predicts lack of activity of cetuximab plus irinotecan treatment 143
NUT rearrangement is uncommon in human thymic epithelial tumors 143
Array comparative genomic hybridization of thymic epithelial tumors identifies loss of CDKN2A as a prognostic factor and BCL2 family members as targets for therapy 142
First line treatment of metastatic colorectal cancer (MCRC) with the combination of capecitabine, irinotecan, and oxaliplatin (XELOXIRI): Preliminary results of a pilot study by the G.O.N.O. Group 140
Mutations of epigenetic regulatory genes are common in thymic carcinomas 140
Phase II trial of sorafenib in combination with 5-fluorouracil infusion in advanced hepatocellular carcinoma 139
Recent advances in epigenomics in NSCLC: Real-time detection and therapeutic implications 139
Somatic mutations of thymic epithelial tumors with myasthenia gravis 138
Single-cell sequencing has revealed a more complex array of thymic epithelial cells 136
Thymectomy in myasthenic patients with thymoma: killing two birds with one stone 136
Copy number aberrations of genes regulating normal thymus development in thymic epithelial tumors 136
KRAS mutations as potential mechanism of crizotinib acquired resistance: a study on circulating tumor DNA 135
ED-B-Containing Isoform of Fibronectin in Tumor Microenvironment of Thymomas: A Target for a Theragnostic Approach 134
Palliative gastrectomy in asymptomatic metastatic esophagogastric cancer (EGC): does it make sense? 134
Whole Genome and Transcriptome Sequencing of a B3 Thymoma 133
Thymic malignancies: From clinical management to targeted therapies 132
Expression and mutational status of c-kit in thymic epithelial tumors 132
Incidence of T790M in Patients With NSCLC Progressed to Gefitinib, Erlotinib, and Afatinib: A Study on Circulating Cell-free DNA 132
Different gamma/delta T clones sustain GVM and GVH effects in multiple myeloma patients after non-myeloablative transplantation 132
GTF2I MUTATIONS ARE FREQUENT IN THYMIC EPITHELIAL TUMORS 131
Myelodysplastic Syndromes: A Multidisciplinary Integrated Diagnostic Work-up for Patients' Risk Stratification 128
Reproducibility of the WHO classification of thymomas: Practical implications 128
COMPLETE GENOME SEQUENCING OF A HUMAN B3 THYMOMA 126
Totale 16.914
Salva come PNG Salva come JPEG
Categoria #
all - tutte 63.813
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.813
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.216 0 72 20 52 232 204 42 35 71 61 71 356
2022/20231.632 207 243 112 103 144 173 22 119 329 11 156 13
2023/20241.482 106 109 174 88 157 277 72 52 15 137 125 170
2024/20254.286 113 149 48 212 471 440 347 168 361 550 559 868
2025/20265.663 382 630 449 536 538 402 965 300 437 637 247 140
2026/2027597 219 378 0 0 0 0 0 0 0 0 0 0
Totale 21.189